Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000412026 | SCV000490009 | likely benign | Fanconi anemia complementation group O | 2016-09-20 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000409575 | SCV000490010 | likely benign | Breast-ovarian cancer, familial, susceptibility to, 3 | 2016-09-20 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000424810 | SCV000516773 | benign | not specified | 2015-05-18 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Color Diagnostics, |
RCV000580412 | SCV000686362 | likely benign | Hereditary cancer-predisposing syndrome | 2016-04-20 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000679800 | SCV000807173 | likely benign | not provided | 2016-10-03 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000412026 | SCV002444679 | likely benign | Fanconi anemia complementation group O | 2025-02-04 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV003150196 | SCV003838370 | likely benign | Breast and/or ovarian cancer | 2023-04-25 | criteria provided, single submitter | clinical testing | |
KCCC/NGS Laboratory, |
RCV000409575 | SCV005881173 | benign | Breast-ovarian cancer, familial, susceptibility to, 3 | 2025-02-01 | criteria provided, single submitter | clinical testing |